Biopharmaceutical Manufacturing is the innovative process of producing therapeutic drugs and pharmaceuticals using living cells and biological systems. This cutting-edge field combines biology, chemistry, and engineering to create complex molecules that serve as the foundation for advanced medical treatments. Unlike traditional pharmaceuticals, biopharmaceuticals are derived from living organisms, such as bacteria, yeast, or mammalian cells, employing genetic engineering and bioprocessing techniques. Biopharmaceutical Manufacturing plays a pivotal role in delivering biologics, monoclonal antibodies, vaccines, and other personalized medicines, contributing significantly to modern healthcare. Its precision, scalability, and focus on quality make it a cornerstone in the development of advanced therapies, ultimately enhancing patient outcomes. This dynamic field continuously evolves, harnessing the power of science and technology to drive medical innovation forward.
In the realm of Biopharmaceutical Manufacturing, several crucial areas shape the landscape of this dynamic field. Here are the primary focus areas within Biopharmaceutical Manufacturing:
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand